2021
DOI: 10.1016/j.envpol.2021.117078
|View full text |Cite
|
Sign up to set email alerts
|

Perfluorooctane sulfonate alternatives and metabolic syndrome in adults: New evidence from the Isomers of C8 Health Project in China

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
5
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 39 publications
(8 citation statements)
references
References 82 publications
2
5
1
Order By: Relevance
“…Consistent with our study, previous studies also reported high concentrations of PFAS alternatives. For example, the plasma concentration of 6:2 Cl-PFESA concentration was 1.4 ng/mL in our study, which is comparable to 1.75 ng/mL reported by Yu et al 21 in the general population and 1.54 ng/mL by Chen et al 22 in pregnant women in China. Moreover, 6:2 Cl-PFESA, 8:2 Cl-PFESA and HFPO-DA were detected in more than 95% of our population, suggesting that humans are also widely exposed to the PFAS alternatives.…”
Section: Discussionsupporting
confidence: 86%
“…Consistent with our study, previous studies also reported high concentrations of PFAS alternatives. For example, the plasma concentration of 6:2 Cl-PFESA concentration was 1.4 ng/mL in our study, which is comparable to 1.75 ng/mL reported by Yu et al 21 in the general population and 1.54 ng/mL by Chen et al 22 in pregnant women in China. Moreover, 6:2 Cl-PFESA, 8:2 Cl-PFESA and HFPO-DA were detected in more than 95% of our population, suggesting that humans are also widely exposed to the PFAS alternatives.…”
Section: Discussionsupporting
confidence: 86%
“…Consistent with our study, previous studies also reported high concentrations of PFAS alternatives. For example, the plasma concentration of 6:2 Cl-PFESA concentration was 1.4 ng/mL in our study, which is comparable to 1.75 ng/mL reported by Yu et al 19 in the general population and 1.54 ng/mL by Chen et al 20 in pregnant women in China. Moreover, 6:2 Cl-PFESA, 8:2 Cl-PFESA and HFPO-DA were detected in more than 95% of our population, suggesting that humans are also widely exposed to the PFAS alternatives.…”
Section: Discussionsupporting
confidence: 86%
“…However, the relationship of human exposure and overweight/ obesity status is still controversial, given concerns about reverse causality and effective dose (Jain 2020). Due to different modeling approaches and inconsistent confounding variables, the results of some studies were not consistent with ours (Averina et Though there is no evidence that showed Cl-PFESAs might be potential obesogens in human beings, our previous epidemiologic studies found serum Cl-PFESAs concentrations were signi cantly positively associated with serum lipids (Cong et al 2021) and the risk of metabolic syndrome (MetS) (Yu et al 2021). In addition, Yao et al (Yao et al 2020) reported multivariate linear regression coe cients of 9.80% (95% CI: 6.09, 13.63) for cholesterol (mmol/L), 9.59% (95% CI: 5.29, 14.07) for low-density lipoprotein cholesterol (mmol/L), 12.34% (95% CI: 2.80, 2.88) for triglycerides (mmol/L), higher 6:2 Cl-PFESA per lnng/mL concentrations, respectively, which suggests potential elevated lipid parameters from exposure to 6:2 Cl-PFESA.…”
Section: Discussioncontrasting
confidence: 61%